Ajinomoto Co., Inc. v. Int’l Trade Comm’n
Ajinomoto Co.,...Error: No video found
(U.S. Fed. Cir., Drugs & Biotech, Government Law, Intellectual Property, Patent) In plaintiffs’ suit alleging violation of section 337 of the Tariff Act in the importation and sale of certain lysine feed products made by the methods claimed in their patents relating to improved methods of producing L-lysine with genetically engineered E-Coli bacteria, the International Trade Commission’s determination of no section 337 violation is affirmed where: 1) the asserted claims of plaintiffs’ ’698 patent and ’160 patents are invalid under 35 U.S.C. section 112 for failure to comply with the best mode requirement; and 2) plaintiffs’ argument that the Commissioner erred in finding ’698 patent is unenforceable due to inequitable conduct is waived.
